4//SEC Filing
Eggenberg Michael 4
Accession 0001235802-20-000136
CIK 0001453593other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:33 PM ET
Size
30.2 KB
Accession
0001235802-20-000136
Insider Transaction Report
Form 4
Eggenberg Michael
Director10% Owner
Transactions
- Exercise of In-Money
Warrant (right to buy)
2020-11-17−868,016→ 0 total(indirect: See Footnotes)Exercise: $0.01From: 2020-11-06Exp: 2030-05-06→ Common Stock (868,016 underlying) - Exercise of In-Money
Common Stock
2020-11-17$0.01/sh+434,008$4,340→ 16,168,704 total(indirect: See Footnotes) - Exercise of In-Money
Warrant (right to buy)
2020-11-17−765,992→ 0 total(indirect: See Footnotes)Exercise: $0.01From: 2018-09-17Exp: 2028-08-01→ Common Stock (765,992 underlying) - Exercise of In-Money
Common Stock
2020-11-17$0.01/sh+765,992$7,660→ 53,468,376 total(indirect: See Footnotes) - Exercise of In-Money
Common Stock
2020-11-17$0.01/sh+1,531,984$15,320→ 55,766,352 total(indirect: See Footnotes) - Exercise of In-Money
Warrant (right to buy)
2020-11-17−765,992→ 0 total(indirect: See Footnotes)Exercise: $0.01From: 2019-04-11Exp: 2029-04-01→ Common Stock (765,992 underlying) - Exercise of In-Money
Warrant (right to buy)
2020-11-17−434,008→ 0 total(indirect: See Footnotes)Exercise: $0.01From: 2019-04-11Exp: 2029-04-01→ Common Stock (434,008 underlying) - Exercise of In-Money
Warrant (right to buy)
2020-11-17−1,531,984→ 0 total(indirect: See Footnotes)Exercise: $0.01From: 2020-11-06Exp: 2030-05-06→ Common Stock (1,531,984 underlying) - Exercise of In-Money
Common Stock
2020-11-17$0.01/sh+765,992$7,660→ 54,234,368 total(indirect: See Footnotes) - Exercise of In-Money
Common Stock
2020-11-17$0.01/sh+434,008$4,340→ 15,734,696 total(indirect: See Footnotes) - Exercise of In-Money
Common Stock
2020-11-17$0.01/sh+868,016$8,680→ 17,036,720 total(indirect: See Footnotes) - Exercise of In-Money
Warrant (right to buy)
2020-11-17−434,008→ 0 total(indirect: See Footnotes)Exercise: $0.01From: 2018-09-17Exp: 2028-08-01→ Common Stock (434,008 underlying)
Holdings
- 70,423
Common Stock
Footnotes (4)
- [F1]These securities are held of record by ROS Acquisition Offshore LP ("ROS Acquisition"). OrbiMed Advisors LLC ("Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the investment manager of ROS Acquisition. Advisors is also the investment manager of Royalty Opportunities S.a r.l., of which ROS Acquisition is a wholly-owned subsidiary. By virtue of such relationships, Advisors may be deemed to have voting and investment power with respect to the securities held by ROS Acquisition noted above and as a result may be deemed to have beneficial ownership over such securities. Advisors exercises its investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the securities held by ROS Acquisition.
- [F2]Each of ROS Acquisition, OrbiMed Royalty Opportunities II, LP ("ORO II"), Advisors and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes. The Reporting Person is an employee of Advisors.
- [F3]These securities are held of record by ORO II. OrbiMed ROF II LLC ("ROF II") is the general partner of ORO II, and Advisors is the managing member of ROF II. By virtue of such relationships, Advisors may be deemed to have voting and investment power with respect to the securities held by ORO II noted above and as a result may be deemed to have beneficial ownership over such securities. Advisors exercises its investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the securities held by ORO II.
- [F4]These shares are to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the Reporting Person remaining a director of the Company through the vesting date.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001732521
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:33 PM ET
- Size
- 30.2 KB